NCT06982222 2026-03-19
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
Clinical Trials
72 trialsNCT07048314 2026-03-19
Stem Cells for Erectile Dysfunction Post RALP
The Methodist Hospital Research Institute
Phase 1/2 Not yet recruiting
NCT07480044 2026-03-18
A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery
Zhejiang University
Phase NA Not yet recruiting
NCT07476677 2026-03-17
ANDARP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT07478536 2026-03-17
CHAS3
Insel Gruppe AG, University Hospital Bern
Not yet recruiting
NCT07468838 2026-03-16
UroDNA
Institut Cancerologie de l'Ouest
Not yet recruiting
NCT07475533 2026-03-16
Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy
Ankara City Hospital Bilkent
Phase NA Not yet recruiting
NCT07463092 2026-03-13
Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy
University of Sao Paulo
Phase NA Not yet recruiting
NCT07468903 2026-03-13
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT07296887 2026-03-12
CARE Tool Study Aim 3
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07468396 2026-03-12
A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
Gan & Lee Pharmaceuticals.
Phase 1 Not yet recruiting
NCT07468708 2026-03-12
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07441837 2026-03-11
TeLuNa
Ankara University
Phase 2 Not yet recruiting
NCT07463833 2026-03-11
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
UNC Lineberger Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT07460726 2026-03-10
PRIAPUS-PCa
CancerCare Manitoba
Not yet recruiting
NCT07454603 2026-03-06
PROSTest_STRAT
Wren Laboratories LLC
Not yet recruiting
NCT07455058 2026-03-06
VAPOR-LTR
Francis Medical Inc.
Not yet recruiting
NCT07455903 2026-03-06
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Baptist Health South Florida
Phase 2 Not yet recruiting
NCT07437482 2026-03-03
CLEAR-PC
Universidad Miguel Hernandez de Elche
Not yet recruiting
NCT07444983 2026-03-03
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Phase NA Not yet recruiting
NCT07224009 2026-03-02
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
University of Arkansas
Phase 2 Not yet recruiting
NCT07441889 2026-03-02
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
University of Virginia
Phase 1/2 Not yet recruiting
NCT06987045 2026-02-27
TransPRIDE
Queen Mary University of London
Not yet recruiting
NCT07440641 2026-02-27
RE-FIT
University of Vermont
Phase NA Not yet recruiting
NCT06834204 2026-02-25
ACCESS-PC
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07433140 2026-02-25
PROSTIMERSBOP
Koc University Hospital
Phase NA Not yet recruiting
NCT07278362 2026-02-23
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
University of Miami
Phase 4 Not yet recruiting
NCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07426094 2026-02-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07332832 2026-02-18
SEQ-bpMRI
Peking University First Hospital
Not yet recruiting
NCT07377006 2026-02-18
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07234981 2026-02-17
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Patients With Recurrent Prostate Cancer After Prostatectomy
University of Nebraska
Phase 2 Not yet recruiting
NCT07414940 2026-02-17
ACT-RESoLUTE
University College, London
Phase 1/2 Not yet recruiting
NCT07415135 2026-02-17
Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy
RenJi Hospital
Phase 2 Not yet recruiting
NCT07407283 2026-02-12
A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07407686 2026-02-12
INCLUDE PC
Royal Marsden NHS Foundation Trust
Not yet recruiting
NCT07042256 2026-02-09
HIP-PRO
University of Zurich
Phase NA Not yet recruiting
NCT07231627 2026-02-09
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
University of Arkansas
Phase NA Not yet recruiting
NCT07393867 2026-02-06
ARPEGGIO
Brigham and Women's Hospital
Phase 2 Not yet recruiting
NCT07386171 2026-02-04
MUS-AS
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Not yet recruiting
NCT07386496 2026-02-04
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Chinese University of Hong Kong
Phase NA Not yet recruiting
NCT07387263 2026-02-04
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
Phase NA Not yet recruiting
NCT07223385 2026-02-03
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Cedars-Sinai Medical Center
Phase 2 Not yet recruiting
NCT07381582 2026-02-02
161Tb-LNC1011
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07221825 2026-01-29
Low-Count Quantitative SPECT for Men Treated With Radium-223
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07365423 2026-01-29
TerbinaPro
Swiss Cancer Institute
Phase 2 Not yet recruiting
NCT07376057 2026-01-29
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
NCT07004582 2026-01-27
PR3DICT
Maastricht Radiation Oncology
Not yet recruiting
NCT07364071 2026-01-27
SENTRY
University of California, San Diego
Phase 2 Not yet recruiting
NCT07225309 2026-01-26
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting